Exhibitors 2011

 

www.bioalps.org

Founded in 2003, the BioAlps Association is the Life Science clusterof Western Switzerland, supported by the Cantons of Bern, Fribourg, Vaud, Neuchâtel, Geneva, Valais, Jura and the Swiss State Secretariat for Economic Affairs, with a mission of promoting and furthering excellence and performance in MedTech and BioTech developments in this cluster at all levels: regionally, nationally, and in the international arena. It is the entry point to a wealth of contacts, knowhow, knowledge and provides both personal and institutional support.

Everything BioAlps does is geared towards innovation and nurturing creativity in research, education and business to enable novel products and services to reach the market efficiently and quickly. By means of the numerous events that the association organizes and sponsors, and the production of regular documentation as to current developments within the region, BioAlps is able to offer representatives from academic, industrial, financial and political backgrounds a variety of fruitful opportunities to connect with others linked to the life sciences.

www.csem.ch

The Centre Suisse d’Electronique et de Microtechnique (CSEM) SA is a privately held innovation center with its headquarters situated in Neuchâtel, Switzerland. CSEM's mission is to enhance the competitiveness of (particularly Swiss) industry by developing applied technology platforms in micro- and nanotechnologies and ICT, and transferring them to the industrial sector. Some of CSEM’s key application domains are in Life Sciences and Medtech.

www.debiotech.com

DEBIOTECH develops innovative medical devices based on micro- and nano-technology, microelectronics and new materials. More precisely, DEBIOTECH concentrates on implantable and non-implantable devices for drug delivery and diagnostics. DEBIOTECH’s core competence lies in the identification of breakthrough technologies and the development of new devices in this area. These devices are then licensed to major international pharmaceutical and medical device companies.

Examples of such products which are today on the market include IV Express (licensed to Kimal in Europe and USA and JMS in Japan), CT Express commercialised by Swiss Medical Care (a spin-off company of DEBIOTECH recently acquired by Bracco Imaging), Clip&Ject commercialised by West Pharmaceuticals and DebioPass by Hyaltech (a subsidiary of Zeiss).

DEBIOTECH is a world renowned actor in the field of drug delivery based on MEMS (MicroElectroMechanical Systems) technology. The company is developing, in addition to the Nanoject Microneedles for intradermal injection (CTI Medtech Award 2008), a patch pump for continuous subcutaneous infusion of insulin (Swiss Technology Award 2006).

www.epfl.ch

EPFL (Ecole Polytechnique Fédérale de Lausanne) is one of two Swiss Federal Institutes of Technology. It has three missions: education, research and technology transfer at the highest international level. EPFL, in its idyllic location on the shores of Lake Geneva, brings together a campus of more than 10,000 people. By its novel structure, the school stimulates collaboration between students, professors, researchers and entrepreneurs. These daily interactions give rise to new and groundbreaking work in science, technology and architecture.

www.nanoink.net

NanoInk provides direct write, tip-based desktop lithography instruments and services for nano and micro scale patterning. The product portfolio optimizes controllable deposition of different materials, under ambient conditions, to rapidly generate user-defined multiplexed patterns with feature sizes 50 nm to 10 microns, enabling cutting edge nanofabrication, nanoengineering and nanobiological applications.

www.nbmolecules.com

Nano Bridging Molecules (NBMolecules®), is a privately held Swiss Medical Device/Life Science Research and Development company, focusing on the development of breakthrough surface treatments for dental and orthopedic implants.

The patented surface treatment SurfLink® allows faster and better integration of implants to living bone also referred to as ‘osseointegration’. This is mainly due to SurfLink®’s biomimicking characteristics.

NBMolecules® SurfLink® technology has been developed over a period of 12 years by a multidisciplinary team from a number of renowned academic institutions including the University of Geneva (‘UniGe’), Ecole Polytechnique Fédérale de Lausanne (‘EPFL’), the University of Zürich and the University of Bern. NBMolecules® SurfLink® technology is protected by patents owned by the UniGe and EPFL. According to a license agreement entered into with UniGe and EPFL, the university spin-off company NBMolecules®, established in 2002, owns the worldwide exclusive right to full and unrestricted use, development and exploitation of the technology.

SurfLink® Dental, NBMolecules® first dental implant surface treatment, is produced under the ISO 13485 certification and was granted a CE-mark in May 2011. SurfLink® Dental was launched in October 2011 at the European Association of Osseointegration (EAO).

www.scienion.de

SCIENION AG is a Dortmund and Berlin-based company offering complete solutions in the field of parallel bioanalytics.

Products and services are targeted mostly for academic research, biotech, pharma and diagnostic companies where they are deployed for biochip and biosensor manufacturing.

Scienion has developed integrated technologies for controlling droplet formation, volume measurement and quality assessment of the spotted array.

[Top]  

© Nanotech-Montreux, Lausanne, Switzerland, 2011